Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost
Includes bibliographical references.
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Sociology
2014
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613159619035138 |
|---|---|
| access_status_str | Open Access |
| author | Roberts, Thomas Gerald |
| author_browse | Roberts, Thomas Gerald |
| author_facet | Roberts, Thomas Gerald |
| author_sort | Roberts, Thomas Gerald |
| collection | Thesis |
| description | Includes bibliographical references. |
| format | Thesis |
| id | oai:open.uct.ac.za:11427/5959 |
| institution | University of Cape Town (South Africa) |
| language | eng |
| last_indexed | 2026-06-10T12:31:43.046Z |
| license_str | Not specified — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository |
| publishDate | 2014 |
| publishDateRange | 2014 |
| publishDateSort | 2014 |
| publisher | Department of Sociology |
| publisherStr | Department of Sociology |
| record_format | dspace |
| source_str | UCTD — University of Cape Town Open Access Repository |
| spelling | oai:open.uct.ac.za:11427/5959 Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost Roberts, Thomas Gerald Sociology Includes bibliographical references. Recently, effective oral cancer drugs are gaining prominence. This trend toward oral chemotherapy has important economic implications: the Medicare system of the United States pays for all intravenous (IV) chemotherapy, but it covers only those oral drugs that have an equivalent IV formulation approved by the Food and Drug Administration (FDA). The majority of oral cancer drugs in the cancer pipeline do not have such an IV equivalent. There are two proposals before the United States Congress to expand the Medicare program to cover all oral cancer drugs. Gefitinib (Iressa; AstraZeneca) is one of the most interesting of the cohort of novel, targeted oral cancer drugs. Already approved in Japan, it is currently under review by the U.S. FDA. This drug has relatively modest efficacy and few side effects; but it is likely to be expensive. Because the sponsor is seeking approval for the treatment of lung cancer, with a large annual incidence, the economic implications of an FDA approval for gefitinib have raised considerable concern. 2014-08-02T07:32:06Z 2014-08-02T07:32:06Z 2003 Master Thesis Masters MSocSc http://hdl.handle.net/11427/5959 eng application/pdf Department of Sociology Faculty of Humanities University of Cape Town |
| spellingShingle | Sociology Roberts, Thomas Gerald Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| thesis_degree_str | Master's |
| title | Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| title_full | Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| title_fullStr | Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| title_full_unstemmed | Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| title_short | Can Medicare afford to pay for oral chemotherapy drugs? : an evaluation of the problem and introduction of a model to estimate cost |
| title_sort | can medicare afford to pay for oral chemotherapy drugs an evaluation of the problem and introduction of a model to estimate cost |
| topic | Sociology |
| url | http://hdl.handle.net/11427/5959 |
| work_keys_str_mv | AT robertsthomasgerald canmedicareaffordtopayfororalchemotherapydrugsanevaluationoftheproblemandintroductionofamodeltoestimatecost |